# Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

> **NCT00079638** · PHASE4 · COMPLETED · sponsor: **Kos Pharmaceuticals** · enrollment: 300 (—)

## Conditions studied

- Dyslipidemia
- Coronary Heart Disease
- Atherosclerosis
- Stroke
- Diabetes

## Interventions

- **DRUG:** Niacin
- **DRUG:** Atorvastatin
- **DRUG:** Simvastatin
- **DRUG:** Ezetimibe
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00079638
- **Lead sponsor:** Kos Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 300 (—)
- **Last updated:** 2006-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079638, "Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00079638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*